# OnCo record nct07110103 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07110103/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07110103", "NCT07110103" ;
  schema:name "Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC"@en ;
  schema:alternateName "JACKPOT38"@en ;
  schema:description "A phase 2 trial of golidocitinib in lung cancer, run by Cancer Institute and Hospital, Chinese Academy of Medical Sciences, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07110103/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07110103> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "lung-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/extensive-stage-sclc/> ;
  onco:drugs <https://onco.cc/drugs/golidocitinib/> ;
  onco:companies <https://onco.cc/companies/dizal/> .